Introduction
Interleukin 8 is secreted from activated monocytes (1) (2) (3) , T lymphocytes (4), fibroblasts (5) , and endothelial cells (6, 7) and is a potent effector of neutrophils (8) and perhaps also of T lymphocytes (9) . This peptide stimulates neutrophil chemotaxis, calcium mobilization (I0), morphological polarization (1 1), and, in the presence of cytochalasin-B, azurophil granule release (10, I 1). IL-8 also modulates neutrophil:endothelial interaction, causing an up to two-to threefold increase in neutrophil adhesion to resting (and therefore relatively nonadherent) endothelium (12, 13), but a 70-90% decrease in adhesion to cytokine-activated (and therefore highly adherent) endothelium (I4). The nature ofthe effects ofIL-8 administered in vivo (maximal sensitivity 50 pM) performed as previously described (19) . Enzyme-linked immunosorbant assay for tissue-type plasminogen activator was carried out as described by Ramakrishnan et al. (20) .
Isolation of blood cells. Neutrophils were isolated as described by Wheeler et al. (21) . Erythrocytes were isolated by a modification ofthe procedures of Nakao et al. (22) and Beutler et al. (23) . Briefly, fresh whole blood was drawn into a heparinized syringe (10 U heparin/ml whole blood) from healthy human volunteers or animals. Different blood donors were used for replicate experiments. Whole blood was then passed over two tandem 20-ml polypropylene syringes that were packed with microcrystalline cellulose/Sephadex G25 (in 3:1 ratio) and that contained cotton filters at their outlets. The columns were washed with 5-10 vol of 0.154 M NaCl. The erythrocyte-containing eluate was then washed thrice by centrifugation at 1,000 g and resuspension in PBS containing 1% BSA. Blood cell counts were performed on a Baker 9000 hematology analyzer (Baker Instrument Co., Allentown, PA) to check for removal of white blood cells and platelets. It was determined that it was occasionally necessary to have the second column in series in order to achieve removal of greater than 99% of the leukocytes. Erythrocyte ghosts were prepared from outdated red blood cells as described by Hanahan and Ekholm (24) .
Measurement of IL-8 binding. Freshly isolated erythrocytes were diluted with binding medium (PBS containing 1% BSA) to achieve the desired cell concentrations. 250 ,l of the washed cells were then sedimented for I min at 13,000 gin a microfuge. 125 Ml of the supernatant was replaced with binding medium containing '25IIL-8 plus or minus nonlabeled IL-8 as indicated. The cells were resuspended and incubated for 15 min at 370C, unless otherwise indicated, and layered atop 0.5 ml of binding medium containing 20% sucrose. The cells were sedimented by centrifugation for 3 min in a microcentrifuge at 13,000 g, and the radioactivity in the cell pellet and supernatant quantified in a Packard Minaxi 5000 series gamma counter (Packard Instruments Co., Inc., Downers Grove, IL). In the case of red cell ghosts, the binding assay was modified as follows. At the end of the binding incubation the contents ofthe binding incubation mixture were quickly diluted with 5 vol of PBS, and the ghosts were pelleted by 25 min centrifugation at 16,000 g.
The fraction of'251I-IL-8 molecules that had specific binding activity was determined by carrying out a 15-min incubation of red cells with 10,000 cpm of the radiolabeled ligand plus or minus 1 MM nonlabeled IL-8. The "bindable" fraction was estimated from the Y axis intercept of a plot of the inverse of specifically bound radioactivity (on the Y axis) versus the inverse of cell concentration (on the X axis), as recently described by Besemer et al. (25 As predicted by radioimmunoassay of IL-8 added to whole blood (Table I) (Fig. 5 E) . Although this Resistance of cell-bound polypeptide ligands to extraction by pH 2.5-3.0 buffer on ice is a commonly used criterion for internalized ligand because, in general, noncovalent protein: protein interactions are disrupted at this pH (31, 32) . Red cells were incubated with '25I-IL-8 for various times at 37°C and then incubated in 0.1 M glycine buffer (pH 3) for 3 min on ice. As shown in Fig. 6 , regardless of the length of time of incubation of red cells with '231-IL-8 (up to 90 min), little ( 20%) of the bound 125I-IL-8 dissociated from the cells upon pH 3 treatment at 5°C. This at first suggested that the ligand had been internalized. However, it was also determined that > 90% of presented). At this temperature the acidic buffer extracted the bound 25II-IL8 as efficiently as did excess nonlabeled IL-8. It is noteworthy that the opposite effect of temperature on pH 3 extraction of neutrophil-bound 125I-IL-8 (sensitivity at 4°C and resistance at 37°C) has been reported (25) . The possibility that the red cell binding sites for IL-8 were located on the plasma membrane was supported by the finding that red cell ghosts specifically bound '25I-IL-8 (data not shown; see Methods for experimental details).
Red cell binding of '25I-IL-8 was not significantly altered by preincubation of the cells with high levels of trypsin (100 MM).
However, preincubation of the cells with similar amounts of chymotrypsin or pronase reduced their specific binding of 125I-IL-8 by 50 and 100%, respectively (Fig. 7 A) . These treatments did not cause detectable hemolysis. The loss of binding was not caused by digestion and inactivation of the '"I-IL-8 ligand by residual protease that did not wash off of the red cells after their protease treatment. SDS polyacrylamide gel electrophoresis (carried out in the presence of dithiothreitol) and autoradiography indicated that the '25I-IL-8 ligand was intact after the binding incubations (data not presented). Moreover, the recovered ligand bound to red cells that had not been preincubated with protease (Fig. 7 B) . These results thus suggest that the red cell binding site for IL-8 is a protein. bound to red cells is not accessible to neutrophils. Because neutrophils are recognized as a primary target of action (8), we designed an experiment to determine whether IL-8 that was bound to red cells could stimulate neutrophils. The previously described rise in cytosolic free calcium that occurs as an early response of neutrophils to IL-8 (11) was chosen as an indicator of IL-8 signal transmission. Neutrophils were loaded with the calcium-sensitive dye, indo-l, incubated with IL-8, and calcium ion levels measured in a fluorescence-activated cell sorter. Fig. 8 (Fig. 8, A) . IL-8 at 10 pM elicited little if any release of calcium ion (Fig. 8, B ).
Approximately halfofthe cell population mobilized calcium in response to 1.5 nM IL-8 ( Fig. 8, C) , and this fraction approached 100% at 10 nM IL-8 ( Fig. 8, D) . To determine whether IL-8 bound to red cells was accessible to neutrophils, red cells were loaded with IL-8 by incubation with the polypeptide at concentrations from 0.1 to 100 nM. Unbound IL-8 was removed by sedimentation and resuspension of the cells in IL-8-free buffer. The cells were not diluted during the washing step, to prevent the loss ofbound IL-8 that occurs on dilution (Fig. 3) Although there are numerous examples of cytokine and hormone binding proteins in blood (28, 29) , in general these are soluble plasma proteins. We know ofno other case in which the red blood cell acts as a major sink for a signal-transmitting polypeptide. Red cells do bind insulin and insulin-like growth factors, but not so extensively as to substantially reduce the soluble levels of these hormones (37, 38, 39) . The red cell surface is also a key site for control of other proteins that play a role in inflammatory processes. The transmembrane protein CR1 is an essential cofactor for the cleavage ofC3bi, and is also a carrier of immune complexes to the liver for clearance (40, 41) . Decay accelerating factor, which is associated with the red cell membrane by a fatty acyl linkage, inhibits the assembly and accelerates the decay of C3 convertase (41, 42) .
These results, although novel, are generally consistent with the literature. In a recently reported screening study Besemer et al. (25) (43, 25) . The 
